🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To evaluate the efficacy of KEVZARA (sarilumab) in part...
Status
Terminated
Location
Investigational Site Number 8400003
Start Date
2018-10-09
Trial ID
NCT03600818
Primary Objective: To evaluate the efficacy of sarilumab in participants w...
Status
Terminated
Location
Investigational Site Number 8400002
Start Date
2018-11-20
Trial ID
NCT03600805
Treatments Being Tested
This is a single-dose, double-blind, placebo-controlled, parallel group saf...
Status
Completed
Location
Institute of Rheumatology under the Russian Academy of Medical Sciences
Start Date
2008-09
Trial ID
NCT01026519
Primary Objective: \- To demonstrate that sarilumab (SAR153191/REGN88) on ...
Status
Terminated
Location
Investigational Site Number 840026
Start Date
2010-11
Trial ID
NCT01217814
Treatments Being Tested
Phase 2: The primary objective of the study is to evaluate the clinical ef...
Status
Completed
Location
Regeneron Study Site
Start Date
2020-03-18
Trial ID
NCT04315298
Primary Objective: To assess the safety and tolerability of a single dose ...
Status
Completed
Location
Investigational Site Number 392001
Start Date
2013-04
Trial ID
NCT01850680
Treatments Being Tested
Primary Objective: To demonstrate that sarilumab added to disease modifyin...
Status
Completed
Location
Investigational Site Number 840070
Start Date
2012-10
Trial ID
NCT01709578
Treatments Being Tested